Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Progesterone may help trans women with breast development and health, but more research is needed.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

The document aimed to improve healthcare providers' understanding of hormone therapy for transgender and nonbinary patients.

Testosterone treatment may affect heart response to stress in transgender men.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Topical 3% minoxidil effectively and safely enhances facial hair in transgender men.

Use topical treatments for mild acne and oral treatments for moderate to severe acne, avoiding antibiotic monotherapy.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Denying transgender minors gender-affirming care, while allowing it for cisgender minors, is sex discrimination.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.